Skip to main content

Table 1 Characteristics of participants by treatment condition

From: Long-term effects of the Mediterranean lifestyle program: a randomized clinical trial for postmenopausal women with type 2 diabetes

  Mean (SD) or Percent  
Characteristic Usual Care (N = 116) MLP (N = 163) Significance (p Value)
Age 60.7 (7.8) 61.1 (8.0) .70
Weight (kg) 93.9 (23.8) 92.3 (21.2) .55
Waist/hip ratio 0.9 (.08) 0.91 (.08) .35
Body mass index (kg/m2) 35.6 (8.8) 35.1 (7.7) .62
Age diagnosed with diabetes 52.5 (10.7) 53.0 (10.0) .71
Years taking medications 5.0 (6.3) 4.9 (4.9) .90
Years diagnosed with diabetes 8.5 (8.3) 8.2 (7.3) .77
Current smoker (% yes) 10.3 8.7 .59
Income    .22
   % $0 to $ 9,999 14.9 5.8  
   % $10,000 to $19,999 21.9 24.5  
   % $20,000 to $29.999 17.5 23.9  
   % $30,000 to $39,000 17.5 14.2  
   % $40,000 to $49,000 10.5 11.0  
   % $50,000 to $59,999 9.5 5.8  
   % $60,000 to $69,999 0.9 5.2  
   % $70,000 to $79,999 1.7 3.9  
   % $80,000 or more 5.2 5.8  
Type of glucose-lowering medication    .62
   % None 17.2 24.7  
   % Oral medication only 61.2 54.9  
   % Insulin only 12.1 7.4  
   % Insulin and oral medication 9.5 13.0  
Present living arrangement    .43
   % With spouse 49.1 51.5  
   % With spouse and children 11.2 9.8  
   % With children or others 9.4 14.7  
   % Alone 30.2 23.9  
Level of education achieved    .72
   % 0 to 11th grade 11.2 8.5  
   % High school graduate 25.0 25.2  
   % Some college 39.7 43.6  
   % College/university graduate 24.1 22.7  
   % Caucasian 94.8 92.0 .59
Medications    
   % Taking lipid-lowering 40.5 38.9 .79
   % Taking blood pressure-lowering 47.4 46.3 .86
   % Taking estrogen replacement therapy 46.6 59.3 .04
Number of comorbidities    .27
   % With no other disease 4.3 4.9  
   % With 1–2 other diseases 43.1 50.9  
   % With ≥ 3 other diseases 52.6 44.2  
Most prevalent comorbidities    
   % Having CHD 15.0 14.0 .26
   % Having arthritis 50.9 56.4 .36
   % Having high blood pressure 72.4 70.6 .74
   % Having back problems 37.9 33.1 .41